Pyxis Oncology Inc (PYXS) Price Prediction & ForecastPYXSPyxis Oncology Inc

Alphio's PYXS stock price prediction model matches the current Pyxis Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.51 (-6.93%). The 1-week path is $1.55 (-4.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Pyxis Oncology Inc (PYXS) is trading at $1.69, significantly below its 52-week high of $5.55, indicating a potential for recovery. However, the RSI is at 35.47, suggesting it is nearing oversold territory, but not yet a strong buy signal. The forward P/E ratio is currently at 0, which indicates uncertainty in earnings expectations. The recent public offering priced at $2.90 per share raised $110 million, but the stock has dropped 8.62% in pre-market trading, reflecting market skepticism. The main risk is the company’s substantial net losses, with a net income of -$25.35 million projected for Q2 2026, which could deter investors. Therefore, while there are potential catalysts, such as the FDA Fast Track Designation for its drug MICVO, the current price action and financial performance suggest holding rather than buying at this moment.

Pyxis Oncology Inc (PYXS) last closed at $1.6174999, losing -2.56%. These facts feed the 1-day and 1-week PYXS price prediction above.